161 related articles for article (PubMed ID: 16740789)
1. The cancer and leukemia group B respiratory committee.
Vokes EE; Perry MC; Kindler HL; Green MR
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3581s-8s. PubMed ID: 16740789
[TBL] [Abstract][Full Text] [Related]
2. Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial.
Sorensen M; Lassen U; Palshof T; Jensen BB; Johansen J; Jensen PB; Langer SW
Lung Cancer; 2008 May; 60(2):252-8. PubMed ID: 18036701
[TBL] [Abstract][Full Text] [Related]
3. Chemoradiation for unresectable stage III non-small cell lung cancer.
Price KA; Azzoli CG; Gaspar LE
Semin Thorac Cardiovasc Surg; 2008; 20(3):204-9. PubMed ID: 19038729
[TBL] [Abstract][Full Text] [Related]
4. Sequencing chemotherapy, radiotherapy and surgery in combined modality treatment of stage III nonsmall cell lung cancer.
Maas KW; El Sharouni SY; Smit EF; Schramel FM
Curr Opin Pulm Med; 2007 Jul; 13(4):297-304. PubMed ID: 17534176
[TBL] [Abstract][Full Text] [Related]
5. Activities and accomplishments of the cancer and leukemia group B genitourinary committee.
Small EJ; Halabi S; Kantoff P; D'Amico A; Stadler W; Kelley WK; Mohler J; Bajorin D; Vogelzang NJ
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3596s-600s. PubMed ID: 16740791
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer in the elderly.
Gridelli C; Langer C; Maione P; Rossi A; Schild SE
J Clin Oncol; 2007 May; 25(14):1898-907. PubMed ID: 17488989
[TBL] [Abstract][Full Text] [Related]
7. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone.
Huang EH; Liao Z; Cox JD; Guerrero TM; Chang JY; Jeter M; Borghero Y; Wei X; Fossella F; Herbst RS; Blumenschein GR; Moran C; Allen PK; Komaki R
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):779-85. PubMed ID: 17418967
[TBL] [Abstract][Full Text] [Related]
8. Concurrent chemoradiotherapy for limited-disease small cell lung cancer in elderly patients aged 75 years or older.
Shimizu T; Sekine I; Sumi M; Ito Y; Yamada K; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
Jpn J Clin Oncol; 2007 Mar; 37(3):181-5. PubMed ID: 17426103
[TBL] [Abstract][Full Text] [Related]
9. The cancer and leukemia group B pharmacology and experimental therapeutics committee: a historical perspective.
Ratain MJ; Miller AA; McLeod HL; Venook AP; Egorin MJ; Schilsky RL
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3612s-6s. PubMed ID: 16740794
[TBL] [Abstract][Full Text] [Related]
10. Combined modality therapy for stage III non-small cell lung cancer.
Stinchcombe TE; Fried D; Morris DE; Socinski MA
Oncologist; 2006; 11(7):809-23. PubMed ID: 16880240
[TBL] [Abstract][Full Text] [Related]
11. Combined modality treatment of lung cancer (NSCLC and SCLC).
Delbaldo C; Le Péchoux C; Le Chevalier T
Cancer Chemother Biol Response Modif; 2002; 20():677-95. PubMed ID: 12703230
[No Abstract] [Full Text] [Related]
12. Non-small cell lung carcinoma of the superior sulcus: favourable outcomes of combined modality treatment in carefully selected patients.
Kappers I; Belderbos JS; Burgers JA; van Zandwijk N; Groen HJ; Klomp HM
Lung Cancer; 2008 Mar; 59(3):385-90. PubMed ID: 17913281
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
Davies AM; Chansky K; Lau DH; Leigh BR; Gaspar LE; Weiss GR; Wozniak AJ; Crowley JJ; Gandara DR;
J Clin Oncol; 2006 Nov; 24(33):5242-6. PubMed ID: 17114656
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of lung cancer in the elderly].
Diab S; Geriniere L; Carrie C; Souquet PJ
Rev Mal Respir; 2004 Nov; 21(5 Pt 3):8S59-69. PubMed ID: 15803539
[TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy followed by concurrent chemoradiation for patients with non-operable stage III non-small-cell lung cancer.
Iranzo V; Bremnes RM; Almendros P; Gavilá J; Blasco A; Sirera R; Camps C
Lung Cancer; 2009 Jan; 63(1):63-7. PubMed ID: 18550204
[TBL] [Abstract][Full Text] [Related]
16. Concurrent end-phase boost high-dose radiation therapy for non-small-cell lung cancer with or without cisplatin chemotherapy.
Graham PH; Clark C; Abell F; Browne L; Capp A; Clingan P; De Sousa P; Fox C; Links M
Australas Radiol; 2006 Aug; 50(4):342-8. PubMed ID: 16884421
[TBL] [Abstract][Full Text] [Related]
17. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer.
Yuan S; Sun X; Li M; Yu J; Ren R; Yu Y; Li J; Liu X; Wang R; Li B; Kong L; Yin Y
Am J Clin Oncol; 2007 Jun; 30(3):239-44. PubMed ID: 17551299
[TBL] [Abstract][Full Text] [Related]
18. Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.
Mauri D; Pentheroudakis G; Bafaloukos D; Pectasides D; Samantas E; Efstathiou E; Kalofonos HP; Syrigos K; Klouvas G; Papakostas P; Kosmidis P; Fountzilas G; Pavlidis N;
Anticancer Res; 2006; 26(4B):3175-81. PubMed ID: 16886653
[TBL] [Abstract][Full Text] [Related]
19. [Multimodal therapy of small cell and non-small cell lung carcinoma].
Serke M; Kollmeier J
Dtsch Med Wochenschr; 2007 Jun; 132(22):1221-4. PubMed ID: 17520508
[TBL] [Abstract][Full Text] [Related]
20. [Neoadjuvant chemoradiation in non-small cell lung cancer].
Milleron B; Girard N; Gounant V; Mornex F
Cancer Radiother; 2007; 11(1-2):36-40. PubMed ID: 17055314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
